Compounds > azacitidine

azacitidine and T-Cell Lymphoma

azacitidine has been researched along with T-Cell Lymphoma in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (9.09)	18.2507
2000's	4 (36.36)	29.6817
2010's	3 (27.27)	24.3611
2020's	3 (27.27)	2.80

Authors

Authors	Studies
Cho, J; Kim, SJ; Kim, WS; Kim, YJ; Yoon, SE	1
Barta, SK	1
Bates, SE; Califano, A; Casadei, B; Deng, C; Douglass, E; Falchi, L; Kinahan, C; Lue, JK; Marchi, E; Montanari, F; O'Connor, OA; Qiao, C; Renu, N; Safari, M; Scotto, L	1
Cheminant, M; Delarue, R; Dupuis, J; Fataccioli, V; Gaulard, P; Haioun, C; Hermine, O; Lemonnier, F; Marçais, A; Pelletier, L; Robe, C; Sarkozy, C; Sujobert, P; Tournillhac, O	1
Cavelier, L; Pandzic, T; Sander, B; Tobiasson, M; Wahlin, BE	1
Asnafi, V; Bruneau, J; Cheminant, M; Couronne, L; Delarue, R; Derrieux, C; Frenzel, L; Guermouche, H; Hermine, O; Kosmider, O; Lemonnier, F; Lhermitte, L; Macintyre, E; Molina, T; Saillard, C; Suarez, F; Trinquand, A	1
Bueno, MJ; Calin, GA; Cigudosa, JC; Croce, CM; Fernández-Piqueras, J; Gómez de Cedrón, M; Malumbres, M; Pérez de Castro, I; Santos, J	1
Demers, M; Magnaldo, T; Mercier, J; Moisan, S; Potworowski, EF; St-Pierre, Y	1
Aozasa, K; Hoshida, Y; Nakatsuka, S; Nishii, K; Nishiu, M; Takakuwa, T; Tomita, Y; Yamaguchi, M; Yang, WI	1
Koeffler, HP; Matsushita, M; Seo, H; Taguchi, H; Takeuchi, S; Tsukasaki, K; Yang, Y; Yoshino, N	1
Baylin, SB; Herman, JG; Katzenellenbogen, RA	1

Other Studies

11 other study(ies) available for azacitidine and T-Cell Lymphoma

Article	Year
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma. Clinical lymphoma, myeloma & leukemia, 2022, Volume: 22, Issue:11 Topics: Azacitidine; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Retrospective Studies; Salvage Therapy	2022
Is it prime time for T-cell lymphoma? Blood, 2023, 05-04, Volume: 141, Issue:18 Topics: Azacitidine; CD8-Positive T-Lymphocytes; Humans; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral	2023
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. Molecular cancer therapeutics, 2021, Volume: 20, Issue:8 Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Biomarkers, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Epigenesis, Genetic; Epigenome; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Immunity; Lymphoma, T-Cell; Male; Testis; Tumor Cells, Cultured	2021
Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood, 2018, 11-22, Volume: 132, Issue:21 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Female; Humans; Lymphoma, T-Cell; Male; Middle Aged; Retrospective Studies; Treatment Outcome	2018
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in Leukemia & lymphoma, 2019, Volume: 60, Issue:13 Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Cyclophosphamide; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Female; Homeodomain Proteins; Humans; Immunoblastic Lymphadenopathy; Lymph Nodes; Lymphoma, T-Cell; Mutation; Myelodysplastic Syndromes; Prednisone; Proto-Oncogene Proteins; Repressor Proteins; Transcription Factors; Treatment Outcome; Vincristine	2019
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma. Hematological oncology, 2017, Volume: 35, Issue:4 Topics: Aged, 80 and over; Azacitidine; Female; Humans; Leukemia, Myelomonocytic, Chronic; Lymphoma, B-Cell; Lymphoma, T-Cell	2017
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer cell, 2008, Volume: 13, Issue:6 Topics: 3' Untranslated Regions; Animals; Azacitidine; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 14; Chromosomes, Mammalian; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Loss of Heterozygosity; Lymphoma, T-Cell; Lymphoproliferative Disorders; Mice; Mice, Inbred C57BL; MicroRNAs; Phenylbutyrates; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-abl; Time Factors; Transfection; Up-Regulation; Whole-Body Irradiation	2008
Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia, 2003, Volume: 17, Issue:4 Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Disease Progression; Female; Galectins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Radiation-Induced; Oligonucleotide Array Sequence Analysis; RNA, Messenger; RNA, Neoplasm; Specific Pathogen-Free Organisms; Thymus Neoplasms; Tumor Cells, Cultured	2003
Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer science, 2003, Volume: 94, Issue:1 Topics: Antibodies, Monoclonal; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; B-Lymphocytes; Calcium-Calmodulin-Dependent Protein Kinases; CpG Islands; Death-Associated Protein Kinases; Decitabine; DNA Methylation; Enzyme Induction; fas Receptor; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Jurkat Cells; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Neoplasm Proteins; Neoplastic Stem Cells; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes	2003
Methylation of the MLH1 gene in hematological malignancies. Oncology reports, 2005, Volume: 14, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Antimetabolites, Antineoplastic; Azacitidine; Carrier Proteins; Cell Line, Tumor; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Jurkat Cells; Lymphoma, T-Cell; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm	2005
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood, 1999, Jun-15, Volume: 93, Issue:12 Topics: Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Burkitt Lymphoma; Calcium-Calmodulin-Dependent Protein Kinases; CpG Islands; Death-Associated Protein Kinases; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Humans; Interferon-gamma; Leukemia; Lymphocytes; Lymphoma, T-Cell; Tumor Cells, Cultured	1999